Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
The current price of Abbott Laboratories in the market is โฉ126,049.73, with a 24-hour trading volume of โฉ983.1B. The asset's market cap is โฉ219.55T, after moving 2.23% in the last day.
Tokenized Abbott Laboratories is trading at โฉ127,453.37, with a tokenized market cap of โฉ17.38B and a 24-hour trading volume of โฉ2.77B. The tokenized asset has moved -1.98% in the past 24 hours.